{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:40:13Z","timestamp":1726778413202},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"DOI":"10.7759\/cureus.69750","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:05:21Z","timestamp":1726776321000},"source":"Crossref","is-referenced-by-count":0,"title":["Methylnaltrexone\u2019s Effect on Cholestasis in Trauma Patients"],"prefix":"10.7759","author":[{"given":"Andrew","family":"McCague","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellie G","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Shaneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hal","family":"Piwonka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2017.06.021","article-title":"Opioid-induced acalculous cholecystitis: a review","volume":"38","author":"Gilsbach JM","year":"2017","unstructured":"Gilsbach JM, Hadzic A. Opioid-induced acalculous cholecystitis: a review. J Clin Anesth. 2017, 38:42-46. 10.1016\/j.jclinane.2017.06.021","journal-title":"J Clin Anesth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/187132","article-title":"Acute acalculous cholecystitis: a review of the literature","author":"Tazuma S","year":"2005","unstructured":"Tazuma S, Aihara H. Acute acalculous cholecystitis: a review of the literature. Gastroenterol Res Pract. 2005, 180-189. 10.1155\/2005\/187132","journal-title":"Gastroenterol Res Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1002223","article-title":"Opioid-induced constipation: current treatment strategies and future directions","volume":"16","author":"Camilleri M","year":"2015","unstructured":"Camilleri M, Storr M. Opioid-induced constipation: current treatment strategies and future directions. Expert Opinion Pharmacother. 2015, 16:457-466. 10.1517\/14656566.2015.1002223","journal-title":"Expert Opinion Pharmacother"},{"key":"ref4","article-title":"Opioid-induced gastrointestinal side effects: management strategies","volume":"9","author":"Venu RP","year":"2013","unstructured":"Venu RP, Venu M. Opioid-induced gastrointestinal side effects: management strategies. Gastroenterol Hepatol. 2013, 9:441-449.","journal-title":"Gastroenterol Hepatol"},{"key":"ref5","article-title":"Methylnaltrexone: the role of a peripherally acting opioid antagonist in managing opioid-induced constipation","volume":"15","author":"Tack J","year":"2019","unstructured":"Tack J, Dapoigny M. Methylnaltrexone: the role of a peripherally acting opioid antagonist in managing opioid-induced constipation. Gastroenterol Hepatol. 2019, 15:273-282.","journal-title":"Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2015.02.029","article-title":"Impact of the cardiac arrest mode on cardiac death donor lungs","volume":"195","author":"Yamada T","year":"2015","unstructured":"Yamada T, Chen F, Sakamoto J, Nakajima D, Ohsumi A, Bando T, Date H. Impact of the cardiac arrest mode on cardiac death donor lungs. J Surg Res. 2015, 195:596-603. 10.1016\/j.jss.2015.02.029","journal-title":"J Surg Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.014","article-title":"Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease","volume":"64","author":"Junker AE","year":"2016","unstructured":"Junker AE, Gluud LL, van Hall G, Holst JJ, Knop FK, Vilsb\u00f8ll T. Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease. J Hepatol. 2016, 64:908-915. 10.1016\/j.jhep.2015.11.014","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.11.029","article-title":"A case of upper gastrointestinal bleeding caused by gastric\u00a0tuberculosis","volume":"15","author":"Sharma V","year":"2017","unstructured":"Sharma V, Rana SS, Singh P. A case of upper gastrointestinal bleeding caused by gastric\u00a0tuberculosis. Clin Gastroenterol Hepatol. 2017, 15:e107-e108. 10.1016\/j.cgh.2016.11.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0131-1","article-title":"Methylnaltrexone for opioid-induced gastrointestinal adverse effects: a review of clinical trials","volume":"113","author":"Thomas JM","year":"2018","unstructured":"Thomas JM, Drossman DA. Methylnaltrexone for opioid-induced gastrointestinal adverse effects: a review of clinical trials. Am J Gastroenterol. 2018, 113:1511-1522. 10.1038\/s41395-018-0131-1","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa053","article-title":"Frequency of epidural steroid injections","volume":"21","author":"Mattie R","year":"2020","unstructured":"Mattie R, Schneider BJ, Smith C. Frequency of epidural steroid injections. Pain Med. 2020, 21:1078-1079. 10.1093\/pm\/pnaa053","journal-title":"Pain Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006332.pub3","article-title":"Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care","volume":"6","author":"Candy B","year":"2018","unstructured":"Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev. 2018, 6:CD006332. 10.1002\/14651858.CD006332.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000308","article-title":"Spiritual needs of patients with cancer in palliative care: an integrative review","volume":"11","author":"Mesquita AC","year":"2017","unstructured":"Mesquita AC, Chaves \u00c9CL, Barros GA. Spiritual needs of patients with cancer in palliative care: an integrative review. Curr Opin Support Palliat Care. 2017, 11:334-340. 10.1097\/SPC.0000000000000308","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa137","article-title":"Clinical efficacy of ultrasound-mediated transdermal lidocaine and capsaicin delivery for the treatment of allodynia caused by herpes zoster","volume":"21","author":"Dai YE","year":"2020","unstructured":"Dai YE, Liu SX, Ye L, Zuo YX. Clinical efficacy of ultrasound-mediated transdermal lidocaine and capsaicin delivery for the treatment of allodynia caused by herpes zoster. Pain Med. 2020, 21:3739-3746. 10.1093\/pm\/pnaa137","journal-title":"Pain Med"},{"key":"ref14","article-title":"The role of methylnaltrexone in managing opioid-induced gastrointestinal dysfunction: insights from clinical trials","volume":"12","author":"Hsu A","year":"2016","unstructured":"Hsu A, McCallum RW. The role of methylnaltrexone in managing opioid-induced gastrointestinal dysfunction: insights from clinical trials. Gastroenterol Hepatol. 2016, 12:373-382.","journal-title":"Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain--misconceptions and mitigation strategies","volume":"374","author":"Volkow ND","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain--misconceptions and mitigation strategies. N Engl J Med. 2016, 374:1253-1263. 10.1056\/NEJMra1507771","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015","volume":"65","author":"Rudd RA","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, et al.. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016, 65:1445-1452. 10.15585\/mmwr.mm655051e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz014","article-title":"Endogenous pain inhibitory function: endurance-trained athletes vs active controls","volume":"20","author":"Peterson JA","year":"2019","unstructured":"Peterson JA, Schubert DJ, Campbell J, Bemben MG, Black CD. Endogenous pain inhibitory function: endurance-trained athletes vs active controls. Pain Med. 2019, 20:1822-1830. 10.1093\/pm\/pnz014","journal-title":"Pain Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S211112","article-title":"Innovations in pain management: moving beyond opioids","volume":"12","author":"Darnall BD","year":"2019","unstructured":"Darnall BD, Alford DP. Innovations in pain management: moving beyond opioids. J Pain Res. 2019, 12:2897-2910. 10.2147\/JPR.S211112","journal-title":"J Pain Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/13651820701315307","article-title":"Acute acalculous cholecystitis: challenging the myths","volume":"9","author":"Ganpathi IS","year":"2007","unstructured":"Ganpathi IS, Diddapur RK, Eugene H, Karim M. Acute acalculous cholecystitis: challenging the myths. HPB (Oxford). 2007, 9:131-134. 10.1080\/13651820701315307","journal-title":"HPB (Oxford)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.6.860","article-title":"Acalculous disease of the gall bladder","volume":"29","author":"Williamson RC","year":"1988","unstructured":"Williamson RC. Acalculous disease of the gall bladder. Gut. 1988, 29:860-872. 10.1136\/gut.29.6.860","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198202000-00002","article-title":"Acute acalculous cholecystitis. An increasing entity","volume":"195","author":"Glenn F","year":"1982","unstructured":"Glenn F, Becker CG. Acute acalculous cholecystitis. An increasing entity. Ann Surg. 1982, 195:131-136. 10.1097\/00000658-198202000-00002","journal-title":"Ann Surg"},{"key":"ref22","article-title":"Treatment with methylnaltrexone and IVIG for paraneoplastic gastrointestinal dysmotility","volume":"9","author":"Grover M","year":"2013","unstructured":"Grover M, Camilleri M. Treatment with methylnaltrexone and IVIG for paraneoplastic gastrointestinal dysmotility. Gastroenterol Hepatol. 2013, 9:51-53.","journal-title":"Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000520025","article-title":"Advances in the study of acute acalculous cholecystitis: a comprehensive review","volume":"40","author":"Fu Y","year":"2022","unstructured":"Fu Y, Pang L, Dai W, Wu S, Kong J. Advances in the study of acute acalculous cholecystitis: a comprehensive review. Dig Dis. 2022, 40:468-478. 10.1159\/000520025","journal-title":"Dig Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11524","article-title":"Acute acalculous cholecystitis in hospitalized patients in intensive care unit: study of 5 cases","volume":"8","author":"Mossaab G","year":"2022","unstructured":"Mossaab G, Ben Khlifa M, Karim N, et al.. Acute acalculous cholecystitis in hospitalized patients in intensive care unit: study of 5 cases. Heliyon. 2022, 8:e11524. 10.1016\/j.heliyon.2022.e11524","journal-title":"Heliyon"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/21556660.2013.838169","article-title":"Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus","volume":"2","author":"Viscusi ER","year":"2013","unstructured":"Viscusi ER, Rathmell JP, Fichera A, et al.. Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus. J Drug Assess. 2013, 2:127-134. 10.3109\/21556660.2013.838169","journal-title":"J Drug Assess"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas J","year":"2008","unstructured":"Thomas J, Karver S, Cooney GA, et al.. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008, 358:2332-2343. 10.1056\/NEJMoa0707377","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.8.547","article-title":"Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions","volume":"95","author":"Jones EA","year":"2002","unstructured":"Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM. 2002, 95:547-552. 10.1093\/qjmed\/95.8.547","journal-title":"QJM"},{"key":"ref28","article-title":"Successful treatment with methylnaltrexone and IVIG for paraneoplastic syndrome-associated intestinal pseudo-obstruction","volume":"9","author":"Zhang C","year":"2013","unstructured":"Zhang C, Patel NG, Jacobs WC, et al.. Successful treatment with methylnaltrexone and IVIG for paraneoplastic syndrome-associated intestinal pseudo-obstruction. Gastroenterol Hepatol. 2013, 9:48-51.","journal-title":"Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284865-methylnaltrexones-effect-on-cholestasis-in-trauma-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:05:24Z","timestamp":1726776324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284865-methylnaltrexones-effect-on-cholestasis-in-trauma-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.69750","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}